REG - Manolete Partners - Trading Update

Manolete PartnersAnnouncement

18/10/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231018:nRSR4293Qa&default-theme=true

RNS Number : 4293Q  Manolete Partners PLC  18 October 2023

18 October 2023

 

 

Manolete Partners PLC

("Manolete" or the "Company")

 

Trading Update

 

Manolete Partners plc (AIM:MANO), the leading quoted UK insolvency litigation
financing company, is pleased to provide the following update on trading for
the six months ending 30 September 2023 ("H1 FY24").

 

Steven Cooklin, Chief Executive Officer, commented:

 

"In the first half of the year the business has continued its strong growth
after emerging from the Government suppression of the insolvency sector during
the Covid-19 period. The total number of our new case investments in the first
half of our current trading year is 116% higher than the first half of last
year, mirroring the substantial rise in UK insolvencies in the post-pandemic
period.

 

"We have recently learned that Manolete's already exceptional results on the
initial cases in the Barclays Bounce Back Loan ("BBL") Recovery Pilot has led
to the British Business Bank giving approval to Barclays to extend the scale
of the pilot. We have also received confirmation that another well-known bank
is soon to start their own BBL Recovery programme with Manolete.

 

"As we continue to anticipate further sustained high levels of activity in the
UK insolvency sector, we have added significantly to our in-house Legal and
Net Worth Reporting teams with a number of high-quality new joiners."

 

1.   New Case Investments

 

The following table provides an analysis of the Company's new case investments
over the last 18 months trading, which shows the strong growth we are
experiencing following the ending of the Covid insolvency suppression period:

 

H1 FY24           H2 FY23           H1 FY23

 

Non-BBL Case Investments
146                      132
    83

Barclays BBL Case Investments
33
48                      0

Total New Case Investments                   179
         180                    83

 

The total number of new case investments for H1 FY24 was 179, 116% higher than
the 83 new case investments recorded for the comparative first six months of
the previous financial year ("H1 FY23").

 

The H1 FY23 new case investments were detrimentally impacted as the Company
had only just started to emerge from the temporary two-year suppression of the
UK insolvency market imposed by the UK Government in response to the Covid-19
pandemic. Even after the insolvency laws returned to normal, from 1 April
2022, there was then a necessary seven-month hiatus as Insolvency
Practitioners had to investigate and collate the evidence supporting potential
claims, before being in position to present them to the Company for investment
appraisal.

 

The second half of the previous financial year ("H2 FY23") displayed a sharply
positive rebound: recording the Company's highest ever number of 180 new case
investments, as the UK insolvency market began the return to normal
operations.

That trend has continued into the first six months of the current trading year
H1 FY24. On a trailing 12-month view (H2 FY23 plus H1 FY24) the Company has
signed 359 new case investments. That equates to the Company signing
approximately 1.4 new cases for every business day in that 12-month period,
which far exceeds the Company's best pre-pandemic number of new case
investments of 141 for the 12-months ended 31 March 2020 (0.5 new cases for
every business day in that 12-month period).

 

The H2 FY23 level of new case investments of 180 included 48 cases from the
BBL Recoveries pilot project that the Company is working on with Barclays Bank
Plc (see separate section below for further developments on the Company's BBL
recovery programmes). Excluding the Barclays BBL pilot cases, H2 FY23
therefore recorded an impressive 132 new case investments. In H1 FY24 the
Company invested in a further 33 Barclays BBL cases. Therefore, excluding
Barclays BBL pilot cases, for H1 FY24 the Company recorded 146 new case
investments, an increase of 11% (H1 FY23: 132 cases).

 

2.   Case Completions and Money Multiple

 

In H1 FY24, Manolete completed 116 cases, 22% higher than the 95 cases
completed in H1 FY23. The total value of those 116 cases was £9.2m. The value
of the 95 cases in H1 FY23 was £18.3m but, as previously reported, that
included one exceptionally large case completion of £9.5m. Excluding that one
exceptional case H1 FY23 was £8.8m.

 

The average duration (measured from the date that the Company signed the case
to the date of legal completion) was 11.4 months (H1 FY23: 14.9 months). This
signifies a return to the Company's long established case duration of around
12 months.

 

The Money Multiple for the 116 case completions in H1 FY24 was 2.3x (H1 FY23:
2.2x across 95 completed cases).

 

3.   Average Case Completion Size

 

In reference to the case completion figures above the average size of the 116
case completions in H1 FY24 was £79.3k per case, which is 18% lower than the
£96.8k per case completion in H1 FY23 (excluding the exceptional £9.5m
completion in H1 FY23). This reflects the fact that the first wave of new
cases emerging post-pandemic primarily relate to the high number of smaller UK
companies that tend to take the Creditors Voluntary Liquidation ("CVLs")
insolvency route. It is the high CVL numbers that have driven the current high
growth of overall insolvencies in the UK post-pandemic. It is only in the last
seven months that the UK insolvency market has seen any sustained recovery to
pre-pandemic levels of Administration appointments, which is the usual
insolvency route for larger company insolvencies. As the insolvency market
develops through the current business cycle, the Directors anticipate a return
to higher average case sizes, reflecting a greater mix of larger company
insolvencies.

 

Another factor to note is the various BBL Recovery programmes that the Company
is increasingly involved in. As these only started to impact the Company's
performance metrics from January 2023, these have, so far, not had a material
impact. The maximum BBL is £50,000 per case, so as the number of BBL cases
increase, this is likely to have a more material impact on total average
reported case size. BBL cases should not adversely impact reported Money
Multiples and they tend to settle materially faster than the Company's
long-term average case duration of c.12 months.

 

4.   Gross Cash Recoveries

 

In H1 FY24, Manolete delivered (unaudited) gross cash recoveries from
previously completed cases of £9.0m (H1 FY23: £15.7m) spread across 209
separate completed cases (H1 FY23: 160). Again, excluding the exceptional
£9.5m from the comparative H1 FY23 figure, total gross cash received in H1
FY24 was 45% higher than the H1 FY23 figure of £6.2m (excluding the
exceptional large case). The fact that in H1 FY24 £9.0m the gross cash
receipts were spread over 209 separate cases is a core strength of the
granularity of Manolete's business model.

 

5.   PACCAR

 

Further to our announcement on 1 August 2023 regarding PACCAR Inc & Ors v
Competition Appeal Tribunal & Ors,  2023  UKSC 28, the Company is pleased
to report that the decision in PACCAR has had no adverse impact, necessitating
only very minor amendments to the standard terms of our funding agreements.
Funded Cases typically account for just 5% of Manolete's total case
investments, the 95% majority of our case investments being Purchased Cases,
where PACCAR has no relevance.

 

6.   Building the Business Back to Full Year Profitability

 

Subject to auditor review of the interim accounts, the Directors believe that
the Company will report profitability for H1 FY24 at marginally less than was
reported for H2 FY23. This is primarily due to the reduction in average case
sizes and after the investment in new staff and business development, as the
Company builds capacity to meet the current, and anticipated, significantly
higher business activity levels. Traditionally the second half of the trading
year is the stronger for the business.

The auditor's review of the interim results for the six months ended 30
September 2023 is underway and the Company will inform the market of the
interim results announcement date, in due course.

 

 

For further information please contact:

 

Manolete
Partners

Steven Cooklin (Chief Executive
Officer)                      via Instinctif Partners

 

Peel Hunt (NOMAD and Sole
Broker)                        +44 (0)20 7418
8900

Paul Shackleton

 

Instinctif Partners
                                         +44
(0)20 7457 2020

Tim Linacre

Victoria Hayns

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTUBVVROAURAAA